| Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis EA Kendall, MO Fofana, DW Dowdy The Lancet Respiratory Medicine 3 (12), 963-972, 2015 | 266 | 2015 |
| Antigen-Specific Memory B-Cell Responses to Vibrio cholerae O1 Infection in Bangladesh AM Harris, MS Bhuiyan, F Chowdhury, AI Khan, A Hossain, EA Kendall, ... Infection and immunity 77 (9), 3850-3856, 2009 | 135 | 2009 |
| The epidemiological importance of subclinical tuberculosis. A critical reappraisal EA Kendall, S Shrestha, DW Dowdy American journal of respiratory and critical care medicine 203 (2), 168-174, 2021 | 133 | 2021 |
| Implementation of GenoType MTBDRplus Reduces Time to Multidrug-Resistant Tuberculosis Therapy Initiation in South Africa KR Jacobson, D Theron, EA Kendall, MF Franke, M Barnard, ... Clinical infectious diseases 56 (4), 503-508, 2013 | 121 | 2013 |
| Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in rural South Africa: a retrospective cohort study EA Kendall, D Theron, MF Franke, P Van Helden, TC Victor, MB Murray, ... PLoS One 8 (12), e83480, 2013 | 90 | 2013 |
| Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: a modeling study EA Kendall, SG Schumacher, CM Denkinger, DW Dowdy PLoS medicine 14 (12), e1002472, 2017 | 73 | 2017 |
| Relatedness of Vibrio cholerae O1/O139 Isolates from Patients and Their Household Contacts, Determined by Multilocus Variable-Number Tandem-Repeat Analysis EA Kendall, F Chowdhury, Y Begum, AI Khan, S Li, JH Thierer, J Bailey, ... Journal of bacteriology 192 (17), 4367-4376, 2010 | 71 | 2010 |
| Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis S Ricks, EA Kendall, DW Dowdy, JA Sacks, SG Schumacher, ... BMC medicine 19, 1-13, 2021 | 66 | 2021 |
| MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis EA Kendall, AS Azman, FG Cobelens, DW Dowdy PloS one 12 (3), e0172748, 2017 | 56 | 2017 |
| Transforming the fight against tuberculosis: targeting catalysts of transmission DW Dowdy, AS Azman, EA Kendall, B Mathema Clinical Infectious Diseases 59 (8), 1123-1129, 2014 | 55 | 2014 |
| Memory T-Cell Responses to Vibrio cholerae O1 Infection AA Weil, M Arifuzzaman, TR Bhuiyan, RC LaRocque, AM Harris, ... Infection and immunity 77 (11), 5090-5096, 2009 | 55 | 2009 |
| The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities EA Kendall, PJ Kitonsa, A Nalutaaya, KC Erisa, J Mukiibi, O Nakasolya, ... Clinical Infectious Diseases 72 (12), e1035-e1043, 2021 | 50 | 2021 |
| Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children EA Kendall, E González, I Espinoza, M Tipismana, K Verdonck, D Clark, ... The Journal of pediatrics 155 (5), 700-706, 2009 | 49 | 2009 |
| Molecular determinants of proteolytic disassembly of the reovirus outer capsid JD Doyle, P Danthi, EA Kendall, LS Ooms, JD Wetzel, TS Dermody Journal of Biological Chemistry 287 (11), 8029-8038, 2012 | 45 | 2012 |
| Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise AK Coussens, SMA Zaidi, BW Allwood, PK Dewan, G Gray, M Kohli, ... The Lancet Respiratory Medicine 12 (6), 484-498, 2024 | 44 | 2024 |
| Leptospirosis as a cause of fever in urban Bangladesh EA Kendall, RC LaRocque, DM Bui, R Galloway, MD Ari, D Goswami, ... The American journal of tropical medicine and hygiene 82 (6), 1127-1130, 2010 | 44 | 2010 |
| Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis M Reid, YJP Agbassi, N Arinaminpathy, A Bercasio, A Bhargava, ... The Lancet 402 (10411), 1473-1498, 2023 | 41 | 2023 |
| Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis EA Kendall, AT Fojo, DW Dowdy The Lancet Respiratory medicine 5 (3), 191-199, 2017 | 41 | 2017 |
| Target regimen profiles for treatment of tuberculosis: a WHO document C Lienhardt, P Nahid, ML Rich, C Bansbach, EA Kendall, G Churchyard, ... The European respiratory journal 49 (1), 1602352, 2017 | 40 | 2017 |
| What will it take to eliminate drug-resistant tuberculosis? EA Kendall, S Sahu, M Pai, GJ Fox, F Varaine, H Cox, JP Cegielski, ... The International Journal of Tuberculosis and Lung Disease 23 (5), 535-546, 2019 | 37 | 2019 |